ALNY · Alnylam Pharmaceuticals, Inc. · Exempt Offerings
$165.04
+8.39 (+5.36%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$22.11B
Shares
133.94M
Volume · Nov 13
3.59M
Avg daily vol (3M)
2.04M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
1178670
CUSIP
02043Q107
13F (30d)
589 filings
542 filers
Visit website
Investor relations